Pharmaceutical Company Limited operates as a research-based pharmaceutical company in Japan.
The company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate
(marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole
(marketed as Prevacid, Ogast, Takepron, and other names), the anti-hypertensive agent ca... read more
Specialties and Expertise:Biotechnology, Biopharmaceutical, Healthcare, Health Diagnostics, Hyperimmune Globulin, Therapeutic
Research and Development, Clinical Research, Medicine Manufacturing, Metabolic Treatments, Gout Treatment, Gastrointesti... read more
Size and Minority Status
- Products and services 2
- Сommodity codes 4
TAK-888 is an anti-SARS-CoV-2 polyclonal hyperimmune globulin that aims to treat individuals infected with COVID-19.
Takeda has intitiated the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with COVID-19. It has the expertise to research, develop, and manufacture a potential anti-SARS-CoV-2 polyclonal H-IG - TAK-888.
Takeda provides Alogliptin benzoate as a treatment for hyperglycemia in Type 2 Diabetes.
anti-SARS-CoV-2 polyclonal hyperimmune
globulin (H-IG) to treat high-risk individuals with ...
Therapy Designation from the U.S. Food and
Drug Administration, which is used for the treat...
Existing Contracts 1
Locations Served 2
Public Spend Forum compiles the information shown in GovShop's supplier profiles based on multiple sources and relies on GovShop's supplier and buyer user community to help validate the information. We recommend conducting further due diligence and research to validate the information if accuracy is critical.